Compare MIDD & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIDD | PTGX |
|---|---|---|
| Founded | 1888 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.4B |
| IPO Year | 1995 | 2016 |
| Metric | MIDD | PTGX |
|---|---|---|
| Price | $167.40 | $110.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $180.13 | $108.23 |
| AVG Volume (30 Days) | 436.5K | ★ 511.9K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $3,201,202,000.00 | N/A |
| Revenue This Year | $5.87 | $874.25 |
| Revenue Next Year | $3.22 | N/A |
| P/E Ratio | ★ N/A | $2,215.80 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $110.82 | $49.86 |
| 52 Week High | $169.44 | $113.66 |
| Indicator | MIDD | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 67.08 | 60.57 |
| Support Level | $145.86 | $94.48 |
| Resistance Level | $168.32 | N/A |
| Average True Range (ATR) | 4.97 | 4.90 |
| MACD | 0.82 | 1.35 |
| Stochastic Oscillator | 78.33 | 84.05 |
The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.